ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "prognostic factors and radiography"

  • Abstract Number: 666 • 2018 ACR/ARHP Annual Meeting

    Inflammation on MRI of the Sacroiliac Joints Is Highly Associated with Structural Damage in Axial Spondyloarthritis Patients in Clinical Practice: Data from the ASAS and DESIR Cohorts

    Alexandre Sepriano1, Sofia Ramiro1,2, Robert B.M. Landewé3,4, Maxime Dougados5, Désirée van der Heijde6 and Martin Rudwaleit7, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Zuyderland Medical Center, Heerlen & Leiden University Medical Center, Leiden, Netherlands, 3Zuyderland Medical Center, Heerlen, Netherlands, 4Amsterdam Rheumatology & Immunology Center, Amsterdam, the Netherlands, Amsterdam, Netherlands, 5Department of Rheumatology, Paris Descartes University and Cochin Hospital, Paris, France, 6Leiden University Medical Centre, Leiden, Netherlands, 7Internal Medicine and Rheumatology, Klinikum Bielefeld Rosenhöhe, Bielefeld, Germany

    Background/Purpose: The effect of MRI-detected inflammation on the development of radiographic damage at the sacroiliac joints (SIJ) level in patients (pts) with axial SpA (axSpA)…
  • Abstract Number: 1266 • 2016 ACR/ARHP Annual Meeting

    Predictors of Radiographic Progression in Early Rheumatoid Arthritis Patients Treated By an Aggressive Treat-to-Target Regimen

    Nina P. Sundlisater1, Siri Lillegraven1, Inge C Olsen1, Anna-Birgitte Aga1, Till Uhlig1, Hilde B. Hammer2, D van der Heijde1,3, Tore K. Kvien1, Espen Haavardsholm1 and ARCTIC study group, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept. of Rheumtology, Diakonhjemmet Hospital, Oslo, Norway, 3Dept of Rheumatology, Leiden University Medical Ctr, Leiden, Netherlands

    Background/Purpose: With implementation of tight control strategies and defined treatment targets in rheumatoid arthritis (RA) care, a majority of early RA patients may reach remission…
  • Abstract Number: 557 • 2015 ACR/ARHP Annual Meeting

    Early Intensification of Treatment Induces Superior Outcomes in Two Randomized Trials According to Predicted Vs. Observed Radiographic Progression in Rheumatoid Arthritis

    Adrian Levitsky1, Marius C. Wick2, Timo Möttönen3, Marjatta Leirisalo-Repo4, Leena Laasonen5, Hannu Kautiainen6,7, Markku Korpela8, Ronald F. van Vollenhoven1 and Vappu Rantalaiho8, 1Department of Medicine, Unit for Clinical Therapy Research, Inflammatory Diseases (ClinTRID), The Karolinska Institute, Stockholm, Sweden, 2Radiology, Karolinska University Hospital, Stockholm, Sweden, 3Internal Medicine, Division of Rheumatology, Turku University Central Hospital, Turku, Finland, 4Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 5Helsinki Medical Imaging Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 6Unit of Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland, 7Unit of Primary Health Care, Kuopio University Hospital, Kuopio, Finland, 8Department of Internal Medicine, Center for Rheumatic Diseases, Tampere University Hospital, Tampere, Finland

    Background/Purpose: Predicted vs. Observed Radiographic Progression in early Rheumatoid Arthritis (POPeRA) is a method that has previously confirmed the relative radiographic efficacy of synthetic disease-modifying…
  • Abstract Number: 2595 • 2015 ACR/ARHP Annual Meeting

    Autoantibodies to Citrullinated Fibrinogen, Anti-CCP2 and Anti-MCV Antibodies in Early Rheumatoid Arthritis Patients with Rapid Radiographic Progression at 1-Year

    Yannick Degboé1, Arnaud Constantin2, Delphine Nigon3, Gabriel Tobon4, Martin Cornillet5, Thierry Schaeverbeke6, Gilles Chiocchia7, Pascale Nicaise-Roland8, Leonor Nogueira9, Guy Serre5,10,11, Alain G. Cantagrel12 and Adeline Ruyssen Witrand13,14, 1Rheumatology, Rheumatology Center, Purpan University Hospital, Toulouse, France, 2Inserm U558, Rheumatology Center, Purpan University Hospital, Toulouse, France, 3CHU Purpan, Toulouse, France, 4Rheumatology Department, la Cavale Blanche Hospital, Brest, France, 5Service de Biologie Cellulaire, C.H.U. Purpan, Toulouse, France, 6CHU Bordeaux, Bordeaux, France, 7Immunology-Rheumatology, INSERM U1173, paris, France, 8Immunology Department, Bichat Claude-bernard, Universitary Hospital, APHP, Paris, France, 9Immunology, UMR CNRS 5165, INSERM 1056, Toulouse, France, 10Cell Biology, Purpan University Hospital, Toulouse, France, 11Unité Différenciation Épidermique et Autoimmunité Rhumatoïde, Unité Mixte de Recherche, INSERM,Toulouse, France, Toulouse, France, 12Rheumatology, Centre Hospitalier Universitaire, Toulouse Purpan, Toulouse, France, 13Rheumatolgy, CHU Purpan - Hôpital Pierre-Paul Riquet, Toulouse, France, 14UMR 1027, Inserm, Toulouse, France

    Background/Purpose: We compared the ability of anti-CCP2, anti-mutated citrullinated vimentin (anti-MCV) and anti-citrullinated fibrinogen (AhFibA) antibodies to predict 1-year rapid radiographic progression (RRP; total Sharp…
  • Abstract Number: 2613 • 2014 ACR/ARHP Annual Meeting

    Positive Spine MRI for Inflammation Predicts Radiographic Progression in Patients with Ankylosing Spondylitis

    Walter P. Maksymowych1, S Wichuk2, Z Zhao3, P Chiowchanwisawakit4, RG Lambert5 and Sj Pedersen6, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Department of Medicine, University of Alberta, Edmonton, AB, Canada, 3PLA General Hospital, Beijing, China, 4Mahidol University, Bangkok, Thailand, 5Radiology, University of Alberta, Edmonton, AB, Canada, 6Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark

    Background/Purpose: Inflammation at vertebral corners on MRI has been shown to predict development of syndesmophytes in patients with AS. However, it is unclear at a…
  • Abstract Number: 2141 • 2014 ACR/ARHP Annual Meeting

    Sensitivity to Change of Joint Space Width Measurements in Hand Osteoarthritis in a Two Year Follow-up Study

    W. Damman1, S.E. de Bruin1, B.C. Stoel2, R. van 't Klooster2 and M. Kloppenburg1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Radiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Cartilage loss, represented by joint space width (JSW) on radiographs, is an important outcome measure in hand OA disease course. JSW can be assessed…
  • Abstract Number: 1523 • 2013 ACR/ARHP Annual Meeting

    Presence Of Peripheral Arthritis Delays Spinal Radiographic Progression In Ankylosing Spondylitis: Observation Study Of Korean Spondyloarthropathy Registry (OSKAR) Over 5 Years

    Tae-Jong Kim1, Seunghun Lee2, Kyung-Bin Joo3, Dong-Jin Park4, Yong-Wook Park4, Shin-Seok Lee5 and Tae-Hwan Kim6, 1Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, 2Department of Radiology, Department of Radiology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, 3Department of Radiology, Department of Radiology, Hanynag University Hospital for Rheumatic Diseases, Seoul, South Korea, 4Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 5Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 6Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea

    Background/Purpose: The most unique feature in ankylosing spondylitis (AS) is subchondral eburnation and syndesmophytes, possibly leading to ankylosis and spinal fusion. So far a clear…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology